Description: Describes the changes in insurance regulation on both an international and US perspective.

Description: Summary of ReFocus 2019

Description: This articles discusses the results of a first quarter 2019 online survey sponsored by the Reinsurance Section Council.

Description: Managed care networks are important to control rising health care costs . these need to be priced appropriately to produce the right results for all stakeholders . This includes analysis of utilization and costs for both in and out of network claims . A variety of risk and administrative service options exist for entities assuming such risk .

Description: Description and welcome to the 2020 Canadian Reinsurance Conference including highlight of the key note speaker

Description: Latest outlook on the market size and recent trends associated with the U.S. and Canada Life Reinsurance markets. The SOA Life Reinsurance Survey is an annual survey that exhibits individual and group life data from U.S. and Canadian life reinsurers. Survey results are based on financial information self-reported by reinsurance entities and include new business production and inforce figures.

Description: Heart disease, critical illness insurance and the path to change – a personal essay by Jing Lang, FSA, FCIA, FLMI.

Description: Read the May 2020 issue of Reinsurance News published by the Reinsurance Section. Newsletters provide practical information for the working actuary, articles on trends that impact sections and news about section activities.

Description: This article discusses the closed nature of the Brazilian reinsurance market due to the IRB. The Instituto de Resseguros do Brasil is owned 50% by the 15 insurance companies that are licensed to do business in Brazil and 50% by the Government of Brazil, but the Government owns 100% of the voting shares. All reinsurance business must be transacted with and via the IRB. The process, opportunities and risks associated with this scheme are explored.

Description: In setting future mortality assumptions for pricing, the actuary needs to consider not only recent results and recent annualized mortality improvements, but also must look at the possible impact of possible shocks epidemics, wars, etc.